Blogs

Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis – efficacy findings up to week 12

By Aesthetic Multispecialty Society posted Apr 17, 2020 09:54 AM

  
.
0 comments
0 views

Permalink